Kenvue Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kenvue Inc (KVUE)
Kenvue Inc stock price live, this page displays NYSE KVUE stock exchange data. View the KVUE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kenvue Inc real time stock price chart below.
What Is the Kenvue Inc Stock Price Today?
The Kenvue Inc stock price today is 15.00.
What Is the Stock Symbol for Kenvue Inc?
The stock symbol for Kenvue Inc is ""KVUE.""
What Stock Exchange Does Kenvue Inc Trade On?
Kenvue Inc is listed and trades on the NYSE stock exchange.
Is Kenvue Inc a Good Stock to Buy?
Determining whether Kenvue Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KVUE quote. (ISIN: US49177J1025)
What Is the Kenvue Inc Stock Price Today?
The Kenvue Inc stock price today is 15.00.
What Is the Stock Symbol for Kenvue Inc?
The stock symbol for Kenvue Inc is ""KVUE.""
What Stock Exchange Does Kenvue Inc Trade On?
Kenvue Inc is listed and trades on the NYSE stock exchange.
Is Kenvue Inc a Good Stock to Buy?
Determining whether Kenvue Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KVUE quote. (ISIN: US49177J1025)
Fair Value
An estimate of a Kenvue's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.98
15.33
52 wk Range
14.05
25.17
KVUE Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected in 11 days
1/3
Fair Value
An estimate of a Kenvue's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.9815.33
52 wk Range
14.0525.17
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.53%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.53%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KVUE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Kenvue's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
20.50
Upside
+36.67%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Kenvue Inc Company Profile
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women’s health, wound, and other care products under the Listerine, Johnson’s, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Kenvue Inc SWOT Analysis
Strategic Overhaul | Explore Kenvue's ambitious "Extraordinary Powers" strategy, aimed at simplifying operations and driving innovation across its diverse product portfolio |
Market Challenges | Delve into Kenvue's response to declining organic sales and regulatory scrutiny, including leadership changes and a comprehensive strategic review |
Brand Powe | Learn how Kenvue leverages its iconic brands like Tylenol and Neutrogena to maintain market leadership despite fierce competition in the consumer health secto |
Financial Outlook | Analyst price targets range from $22 to $29, reflecting varied perspectives on Kenvue's potential for operational improvements and long-term value creation |
Kenvue Inc Earnings Call Summary for Q2/2025
- Q2 2025 adjusted EPS of $0.29 missed expectations by 17.14%, revenue of $3.84B fell short by 8.13%
- Stock rose 1.45% pre-market despite earnings miss; organic sales declined 4.2% in Q2
- Full-year 2025 guidance: organic sales to decline low single digits, adjusted EPS projected at $1.00-$1.05
- Company focusing on largest brands, innovation, and operational efficiency amid cautious consumer sentiment
- Considering strategic alternatives to streamline operations; 83% of U.S. business holding or gaining market share
Last Updated: 07/08/2025, 18:12
Read Full TranscriptCompare KVUE to Peers and Sector
Metrics to compare | KVUE | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipKVUEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.9x | 26.1x | 12.2x | |
PEG Ratio | 0.69 | 0.42 | 0.03 | |
Price/Book | 2.6x | 2.5x | 1.5x | |
Price / LTM Sales | 1.9x | 1.8x | 1.0x | |
Upside (Analyst Target) | 40.0% | 100.3% | 19.2% | |
Fair Value Upside | Unlock | 10.9% | 11.0% | Unlock |
Analyst Ratings
6 Buy
11 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 20.50
(+36.67% Upside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
0.29 / 0.35
Revenue / Forecast
3.84B / 4.18B
People Also Watch
FAQ
What Stock Exchange Does Kenvue Trade On?
Kenvue is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Kenvue?
The stock symbol for Kenvue is "KVUE."
What Is the Kenvue Market Cap?
As of today, Kenvue market cap is 28.79B.
What Is Kenvue's Earnings Per Share (TTM)?
The Kenvue EPS (TTM) is 0.74.
When Is the Next Kenvue Earnings Date?
Kenvue will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is KVUE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Kenvue Stock Split?
Kenvue has split 0 times.
How Many Employees Does Kenvue Have?
Kenvue has 22000 employees.
What is the current trading status of Kenvue (KVUE)?
As of 26 Oct 2025, Kenvue (KVUE) is trading at a price of 15.00, with a previous close of 15.09. The stock has fluctuated within a day range of 14.98 to 15.33, while its 52-week range spans from 14.05 to 25.17.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.